Center-Authored Papers

Filters: Keyword is Fluorouracil  [Clear All Filters]
A
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
B
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
C
Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A et al..  2015.  Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.. Journal of the National Cancer Institute. 107(8) Abstract
Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow JR, Hortobagyi GN, Livingston R.  2008.  A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5. Abstract
D
Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF et al..  2008.  Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(27):4449-57. Abstract
G
Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin WJ, Martino S, Albain KS.  2008.  Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(8):1223-30. Abstract
H
Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford DE.  2008.  Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.. Cancer. 112(10):2181-7. Abstract
J
Jacobs C, Lyman G, Velez-García E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L.  1992.  A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 10(2):257-63. Abstract
L
Leichman LP, Goldman BH, Bohanes PO, Lenz HJ, Thomas CR, Billingsley KG, Corless CL, Iqbal S, Gold PJ, Benedetti JK et al..  2011.  S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(34):4555-60. Abstract
Lyman GH, Dale DC, Crawford J.  2003.  Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(24):4524-31. Abstract
M
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP et al..  2009.  Adjuvant chemotherapy in older women with early-stage breast cancer.. The New England journal of medicine. 360(20):2055-65. Abstract
O
O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz J-F, Benedetti JK, André T, Haller DG, Sargent DJ.  2008.  Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(14):2336-41. Abstract
S
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Stolworthy TS, Korkegian AM, Willmon CL, Ardiani A, Cundiff J, Stoddard BL, Black ME.  2008.  Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.. Journal of molecular biology. 377(3):854-69. Abstract
W
Walkley CR, Fero ML, Chien W-M, Purton LE, McArthur GA.  2005.  Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells.. Nature cell biology. 7(2):172-8. Abstract